No description available.

No description available.

No description available.

Poly-(ADP-ribsoyl) Polymerases (PARPs) are a superfamily of enzymes comprised of 17 known isoforms. PARP inhibitors (PARPi) have shown success in clinical trials for the treatment of homologous recombination-deficient cancers. Though proven effective initially, tumors treated with PARPi eventually develop resistance. Combinatorial therapeutics targeting PARP and other pathways that may re-sensitize tumors to PARP inhibition, including PI3K/AKT/mTor pathway, and cell-cycle checkpoints (such as CDKs, CHK, and Wee) are being tested. In this context, the synthetic lethality of cyclin-dependent kinase 1 (CDK1) and PARP1 is known. Evaluation of PARP1 and CDK1 pharmacophores led to the development of the tetrahydro-arylazepinone (TAAP) scaffold as a potential dual PARP1/CDK1 inhibitor. We screened a handful of TAAP analogs against PARP1 in a cell-free assay that identified the low micromolar PARP1 inhibitor 1,2,3,4-tetrahydro-5H-benzo[e][1,4]-diazepin-5-one (TBAP), which served as the lead compound. The analogous 1,2,3,4-tetrahydro-5H-pyrido[2,3-e][1,4]-diazepin-5-one (TPAP) series showed a similar bioactivity profile. Satisfyingly, the N1-benzyl TPAP analogue showed activity in the low nanomolar range. The TAAP series (i.e., 6/7-membered scaffold) unfortunately lacked CDK1 inhibitory activity. Finally, many PARPi's show poor isoform-selectivity. The development of isoform-selective PARPi can clarify the specific function of each PARP isoform and may reduce the adverse side effects shown by PARPi. A handful of TAAP analogs were screened against 13 PARP isoforms, where some compounds demonstrated exquisite PARP1/2 selectivity. Concurrently, we discovered an inhibitor for PARP11, an isoform that lacks any known synthetic ligand. Future directions are suggested towards fine-tuning the structure-activity relationship of TAAP-isoform selective PARPi as well as developing a dual PARP1/CDK1 inhibitor. / Master of Science

La mitose est une phase importante du cycle cellulaire. Les mécanismes de surveillance s'assurent de l'ordre et de l'exécution correcte des événements du cycle cellulaire dont les erreurs peuvent conduire à l'aneuploïdie. Pendant la mitose, la séparation des chromatides sœurs est régulée par le point de contrôle du fuseau mitotique qui s'assure que tous les chromosomes sont correctement alignés sur la plaque métaphasique. L'entrée et la sortie de mitose sont régulées par l'activation et l'inactivation du complexe cycline B/Cdk1. Cette fine régulation fait intervenir de nombreuses kinases et phosphatases. Dans ce projet nous nous sommes intéressés plus particulièrement à deux AGC kinases : RSK2 et Greatwall (Gwl).Au cours de cette étude nous nous sommes proposés d'analyser l'implication de RSK2, substrat majeur de la MAPK, dans le point de contrôle du fuseau mitotique. Nos résultats montrent que RSK2 est essentielle pour l'activité du point de contrôle du fuseau mitotique dans les extraits d'œufs de xénope ainsi que pour la localisation des autres protéines de ce mécanisme de surveillance localisées aux kinétochores. Nous montrons également que RSK2 participe au point de contrôle dans les cellules humaines. En effet, RSK2 est nécessaire à la localisation aux kinétochores de Mad1, Mad2 et Cenp-E, protéines essentielles à l'activité de ce checkpoint. L'entrée et la sortie de mitose sont régulées par le complexe cycline B/Cdk1 et des phosphatases. Gwl est une nouvelle kinase essentielle à l'entrée en mitose et au maintien de l'état mitotique dans les extraits d'œufs de xénope. En effet, nos résultats montrent que Gwl maintient l'état mitotique indépendamment du complexe cycline B/Cdk1, en régulant négativement PP2A, une phosphatase responsable de la déphoshorylation des substrats mitotiques. / Mitosis is an important phase of cell cycle. The Spindle Assembly Checkpoint (SAC) verifies the orders and the events correct execution of the cell cycle, as errors may lead to aneuploidy. During the mitosis, the checkpoint delays the anaphase onset until all chromosomes are correctly attached to the spindle‘s microtubules. Entry and Exit of mitosis are regulated by the activation and inactivation of cyclin B/Cdk1. A lot of kinases and phosphatases are involved in this fine regulation. In this project, we are particularly focusing on two AGC kinases: RSK2 and Greatwall (Gwl).In this study, we analyzed RSK2, a major substrates of MAPK, involvement in SAC. Our results show that RSK2 is essential to the activation of SAC in xenopus egg extracts and for the localization at the kinétochores of the others SAC components. We also show that RSK2 participate in the maintenance of the SAC in human cells. Indeed, RSK2 is necessary for Mad1, Mad2 and Cenp-E localization, essential proteins for SAC activation.Entry and exit of mitosis are regulated by cyclin B/Cdk1 complex and phosphatases. Gwl is a new kinase essential to the entry into mitosis and maintenance of the mitotic state in xenopus egg extracts. Indeed, our results showed that Gwl maintains the mitotic state independently of cyclin B/Cdk1 but with the negative regulation of PP2A, which dephosphorylate the mitotic substrates

La quantité de données générée dans le cadre d'étude à grande échelle du réseau d'interaction protéine-protéine dépasse notre capacité à les analyser et à comprendre leur sens; d'une part, par leur complexité et leur volume, et d'un autre part, par la qualité du jeu de donnée produit qui semble bondé de faux positifs et de faux négatifs. Cette dissertation décrit une nouvelle méthode de criblage des interactions physique entre protéines à haut débit chez Saccharomyces cerevisiae, la complémentation de fragments protéiques (PCA). Cette approche est accomplie dans des cellules intactes dans les conditions natives des protéines; sous leur promoteur endogène et dans le respect des contextes de modifications post-traductionnelles et de localisations subcellulaires. Une application biologique de cette méthode a permis de démontrer la capacité de ce système rapporteur à répondre aux questions d'adaptation cellulaire à des stress, comme la famine en nutriments et un traitement à une drogue. Dans le premier chapitre de cette dissertation, nous avons présenté un criblage des paires d'interactions entre les protéines résultant des quelques 6000 cadres de lecture de Saccharomyces cerevisiae. Nous avons identifié 2770 interactions entre 1124 protéines. Nous avons estimé la qualité de notre criblage en le comparant à d'autres banques d'interaction. Nous avons réalisé que la majorité de nos interactions sont nouvelles, alors que le chevauchement avec les données des autres méthodes est large. Nous avons pris cette opportunité pour caractériser les facteurs déterminants dans la détection d'une interaction par PCA. Nous avons remarqué que notre approche est sous une contrainte stérique provenant de la nécessité des fragments rapporteurs à pouvoir se rejoindre dans l'espace cellulaire afin de récupérer l'activité observable de la sonde d'interaction. L'intégration de nos résultats aux connaissances des dynamiques de régulations génétiques et des modifications protéiques nous dirigera vers une meilleure compréhension des processus cellulaires complexes orchestrés aux niveaux moléculaires et structuraux dans les cellules vivantes. Nous avons appliqué notre méthode aux réarrangements dynamiques opérant durant l'adaptation de la cellule à des stress, comme la famine en nutriments et le traitement à une drogue. Cette investigation fait le détail de notre second chapitre. Nous avons déterminé de cette manière que l'équilibre entre les formes phosphorylées et déphosphorylées de l'arginine méthyltransférase de Saccharomyces cerevisiae, Hmt1, régulait du même coup sont assemblage en hexamère et son activité enzymatique. L'activité d'Hmt1 a directement un impact dans la progression du cycle cellulaire durant un stress, stabilisant les transcrits de CLB2 et permettant la synthèse de Cln3p. Nous avons utilisé notre criblage afin de déterminer les régulateurs de la phosphorylation d'Hmt1 dans un contexte de traitement à la rapamycin, un inhibiteur de la kinase cible de la rapamycin (TOR). Nous avons identifié la sous-unité catalytique de la phosphatase PP2a, Pph22, activé par l'inhibition de la kinase TOR et la kinase Dbf2, activé durant l'entrée en mitose de la cellule, comme la phosphatase et la kinase responsable de la modification d'Hmt1 et de ses fonctions de régulations dans le cycle cellulaire. Cette approche peut être généralisée afin d'identifier et de lier mécanistiquement les gènes, incluant ceux n'ayant aucune fonction connue, à tout processus cellulaire, comme les mécanismes régulant l'ARNm. / The quantity of data generated within the framework of protein-protein interaction network large-scale studies exceeds our capacity to analyze them and to understand their meaning; on one hand, by their complexity and their number, and on the other hand, by the quality of the produced data, which are populated with spurious interactions. This dissertation describes new applications of a protein-fragments complementation assay (PCA) to screen for interactions among all proteins in the budding yeast Saccharomyces cerevisiae. This approach is carried out in intact cells, with proteins expressed in their native contexts and under their endogenous promoter, thus assuring correct post-translational modifications and subcellular localization. A further novel application of PCA is described for investigating proteome wide changes in response to cellular adaptation to stresses, such as nutrient starvations and drug treatments. Finally, as a result of the latter strategy applied to characterizing proteome-wide response to the immunosuppressant drug, rapamycin, I describe the discovery of an unforeseen mechanism of modulating cell cycle progression through control of cyclin mRNA stability. In the first chapter of this dissertation, I present a pairwise screen of interactions among proteins resulting from the ~6000 open reading frames in Saccharomyces cerevisiae. We identified 2770 interactions among 1124 proteins. We estimated the quality of our screen by comparing our results to curated gold standard data and coverage of known interactions to all previous studies. The majority of our interactions were novel, but overlap with data from previous studies was as high as 40%. PCA is based on refolding of the reporter protein from complementary N- and C- terminal fragments following interaction of the two proteins to which they are fused. Thus, reporter activity is sterrically limited to interactions in which the termini of the proteins to which the complementary reporter fragments are fused are sufficiently close in space. In the case of our reporter, this limit was 8 nm. Thus PCA is a molecular ruler, providing information on both direct protein-protein interactions and sterrically restricted distances between proteins in complexes. We benchmarked and demonstrated correct topological relationships for a number of known complexes, including the proteasome, RNA polymerase II and the nuclear pore complex. Thus our study provided, for the first time, a topological map of complex organization in a living cell. The integration of the results from such efforts with those of gene regulation dynamics and protein modifications will lead to a fuller understanding of how complex cellular processes are orchestrated at a molecular and structural level in the living cell. In chapter 2, I describe the results of an application of PCA to study the dynamic rearrangement of the proteome under a specific stress; treatment of cells with rapamycin. The results of these efforts were the identification of a novel mechanism of cell cycle control at the level of cyclin mRNA. Specifically, we discovered that the balance between the phosphorylated and dephosphorylated forms of the Saccharomyces cerevisiae arginine methyltransferase, Hmt1, regulates both its assembly into a hexamer and its enzymatic activity. The Hmt1 activity modulates cell cycle progression through stabilizing the B cyclin CLB2 mRNA. We then used PCA to identify the Hmt1 regulators under rapamycin treatment. We identified the catalytic subunit of the PP2a phosphatase, Pph22, activated by the inhibition of TOR, and the kinase Dbf2, activated during entry into mitosis, as the phosphatase and the kinase responsible for the modification of Hmt1 and for its regulatory functions in the cell cycle. I thus, in the end close the circle I began in this summary, going from large-scale discovery of protein-protein interactions, to mapping dynamics of proteome changes during an adaptation and finally to mechanistic insight into a primordial control mechanism in cellular dynamics. The strategies that we devised to discover this mechanism can be generalized to identify and mechanistically link genes together, including those of unknown function, to any cellular process.

Dans l’histoire évolutive des végétaux, la polyploïdisation a été un phénomène récurrent qui a façonné les génomes, aurait contribué à l’avènement de grandes étapes évolutives et aurait favorisé la survie de nombreuses lignées lors de crises écologiques majeures. Le principal mécanisme d’apparition d’espèces polyploïdes est la polyploïdisation sexuelle, qui implique la formation de gamètes 2n résultant de modifications de la division méiotique. Récemment plusieurs mutants produisant des taux élevés de gamètes 2n ont été identifiés chez A. thaliana. Chez cette espèce, la perte de fonction du gène AtPS1 conduit à la mise en place de fuseaux parallèles en méiose II et celle du gène AtCYCA1;2/TAM à l’omission de la seconde division méiotique. L’objectif de cette thèse a été de déterminer des facteurs et mécanismes responsables de la formation de gamètes 2n, en utilisant le rosier comme modèle végétal. Ces travaux ont permis : (i) d’identifier un facteur abiotique, la température élevée, comme inducteur de production de forts taux de gamètes 2n, (ii) de montrer que la fenêtre de sensibilité à ce facteur est restreinte à la méiose et (iii) de révéler que ces gamètes 2n produits sont principalement issus de la mise en place de fuseaux parallèles en méiose II. Afin de déterminer les mécanismes moléculaires à l’origine de leur formation, deux gènes candidats, RhPS1 et RhCYCA1 ont été identifiés chez Rosa. L’analyse de leur expression a révélé : (i) en condition non inductible, leur forte expression dans les étamines au stade méiose et (ii) la répression rapide de leurs niveaux de transcrits en condition d’induction de gamètes 2n. La fonction méiotique du gène RhPS1 a été validée par complémentation du mutant atps1-1 d’A. thaliana et par l’obtention d’une lignée rosier transgénique p35S::ARNi-RhPS1. Compte tenu de ces résultats, l’étude de la polyploïdisation et de ses mécanismes peut désormais être replacée dans le contexte actuel de changement climatique. / In the evolutionary history of plants, polyploidization has been a recurring phenomenon that has shaped the genomes, might have contributed to the occurrence of major evolutionary step and might have facilitated the survival of many plant families during major ecological crises. The main mechanism of polyploidization is sexual polyploidization, which involves the formation of 2n gametes resulting from meiotic division changes. Recently, mutants highly producing 2n gametes have been isolated in A. thaliana. Loss of AtPS1 gene function leads to parallel spindles orientation in meiosis II and loss of AtCYCA1;2/TAM gene function leads to the omission of the second meiotic division. The aim of this PhD project was to identify factors and mechanisms responsible for the 2n gametes formation, using Rosa as a model. This work permitted to: (i) discover an abiotic factor, high temperature, that can induce a high production of 2n gametes, (ii) show that the sensitivity window to this factor is narrow and restricted to meiosis and (iii) reveal that 2n gamete production in inductive condition, results from parallel spindle orientation in meiosis II. To determine molecular mechanisms responsible for their formation, two candidate genes, RhPS1 and RhCYCA1 were identified in Rosa. Analysis of their expression revealed: (i) their high expression level in stamens at meiosis stage in non-inductive condition and (ii) the rapid repression of their transcript levels under inductive condition. Meiotic gene function of RhPS1 was validated by complementation of atps1-1 mutant and by generating a rose transgenic line p35S:: RNAi-RhPS1. According to these results, polyploidization and its mechanisms can now be replaced in the context of the current climate.

Carcinoma de Células Renais (CCR) representa uma família de tumores distintos com evolução clínica imprevisível. Uma variedade de moléculas tem sido avaliada como marcadores prognósticos para CCR. Ciclina D1, uma proteína reguladora do ciclo celular, encontra-se superexpressa em vários tumores primários. Nosso objetivo é avaliar sua expressão como marcador prognóstico em CCR. Antes disso, traçamos um perfil clínico e histopatológico da amostra e verificamos sua relação com os fatores prognósticos considerados clássicos pela literatura. 109 espécimes de pacientes diagnosticados com CCR foram obtidos entre 2005 e 2010 no Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto USP e submetidos à análise imunoistoquímica juntamente com 07 amostras de tecido renal normal. A maior parte das características epidemiológicas e clínicas de nossa amostra foi similar àquelas descritas na literatura mundial. Houve predomínio do gênero masculino, da raça branca, com idade próxima a 60 anos, frequência de pacientes assintomáticos em torno de 36% e grande prevalência do CCR de células claras (71,55%). A mortalidade específica da doença foi de 13,76%, sendo o CCR de células claras o tipo mais frequente entre os óbitos e casos metastáticos. Os casos que exibiram má evolução clínica, definida pela ocorrência de metástase e/ou óbito por CCR (22,01%), estiveram associados à presença de sintomas ao diagnóstico, maior tamanho tumoral, grupo de estágio alto (III ou IV), grau nuclear de Fuhrman alto (3 ou 4), presença de necrose e de diferenciação sarcomatóide no tumor, além de outros fatores histológicos desfavoráveis (p < 0,01). Isso indica que as variáveis utilizadas na avaliação de prognóstico em países desenvolvidos podem ser aplicadas aos nossos pacientes. Não houve expressão imunoistoquímica de Ciclina D1 nos casos de tecido renal normal. Observou-se heterogeneidade de marcação nuclear intratumoral no total de casos e menor expressão proteica entre os CCR papilífero e cromófobo. Pacientes com tumores com Ciclina D1baixa (até 30% de células positivas) apresentaram má evolução clínica (p = 0,03), maior tamanho tumoral (p = 0,01), presença de sintomas ao diagnóstico (p = 0,04), grau nuclear alto (p = 0,001), presença de necrose (p = 0,004) e de diferenciação sarcomatóide (p = 0,04) no tumor, além de menor sobrevida sem metástase e/ou óbito por CCR (p = 0,03). Após análise multivariada, a expressão de Ciclina D1 não apresentou valor prognóstico independente para má evolução clínica, embora tenha aumentado levemente a acurácia prognóstica do modelo adotado. Em todas as análises realizadas para o CCR de células claras isoladamente, observamos significância estatística semelhante à do total de casos (CCR). Nosso estudo demonstrou que: a proteína Ciclina D1 encontra-se superexpressa em CCR; os tipos de CCR parecem exibir diferentes padrões de marcação imunoistoquímica da Ciclina D1; alta marcação da proteína (acima de 30% de células positivas) esteve associada à boa evolução clínica e à maioria dos fatores prognósticos favoráveis bem estabelecidos na literatura. Novas investigações são necessárias para descobrir que mecanismos levam a seu acúmulo nas células neoplásicas e quais outros eventos podem estar contribuindo para a progressão da doença. / Renal Cell Carcinoma (RCC) is a family of distinct tumors with unpredictable clinical outcome. A variety of molecules have been evaluated as prognostic markers for RCC. Cyclin D1, a cell cycle regulatory protein, is overexpressed in several primary tumors. Our purpose is to evaluate its expression as a prognostic marker in RCC. Before that, we drew a clinical and histopathological profile of the sample and verified its relationship with prognostic factors regarded as classics in literature. 109 specimens from patients diagnosed with RCC were obtained between 2005 and 2010 at Hospital das Clínicas - Ribeirão Preto School of Medicine USP and submitted to immunohistochemical analysis, along with 07 normal kidney tissue samples. Most epidemiological and clinical characteristics of our sample were similar to those described in the literature. There was a predominance of male, Caucasian, aged about 60 years, the frequency of asymptomatic patients around 36%, and high prevalence of clear cell RCC (71.55%). The disease-specific mortality was 13.76%, being the clear cell RCC the most frequent type among deaths and metastatic cases. Cases that exhibited poor clinical outcome, defined by the occurrence of metastasis and/or death by RCC (22.01%), were related to the presence of symptoms at diagnosis, larger tumor size, high stage group (III or IV), high Fuhrman nuclear grade (3 or 4), presence of necrosis and sarcomatoid differentiation in the tumor and other unfavorable histological factors (p < 0.01). This indicates that the variables used in the assessment of prognosis in developed countries can be applied to our patients. There was no immunohistochemical expression of Cyclin D1 in cases of normal kidney tissue. There was intratumoral heterogeneity in nuclear staining in all cases and lower protein expression among papillary and chromophobe RCC. Patients with Cyclin D1low tumors (up to 30% positive cells) showed poor clinical outcome (p = 0.03), larger tumor size (p = 0.01), presence of symptoms at diagnosis (p = 0.04), high nuclear grade (p = 0.001), presence of necrosis (p = 0.004) and sarcomatoid differentiation (p = 0.04) in the tumor and lower survival without metastasis and/or death by RCC (p = 0.03). After multivariate analysis, the expression of Cyclin D1 showed no independent prognostic value for poor clinical outcome, although it has slightly increased the prognostic accuracy of the model adopted. In all analyzes performed for clear cell RCC alone, we observed statistical significance similar to that of the total cases (RCC). Our study showed that: Cyclin D1 protein is overexpressed in RCC; RCC types seem to exhibit different patterns of immunohistochemical staining for Cyclin D1; high protein expression (over 30% positive cells) was related to good clinical outcome and to most favorable prognostic factors well established in the literature. Further investigations are necessary to reveal which mechanisms lead to its accumulation in neoplastic cells and what other events might be contributing to the progression of the disease.

O efeito dos hormônios glicocorticóides (GC) de suprimir o crescimento celular é exercido através de cascatas celulares nas quais a transcrição de genes de resposta primária, mediada direta ou indiretamente pelo receptor de GC, regulam a transcrição e a atividade de um conjunto de genes, incluindo fatores importantes para a progressão no ciclo celular. Entretanto, a conexão funcional entre diversos dos genes ativados ou inibidos por GC e a inibição da proliferação de determinados tipos celulares ainda não é completamente conhecida. Nosso laboratório isolou a variante ST1, a partir da linhagem C6 de glioma de rato, utilizando-a como modelo de estudo do mecanismo de ação de GC como agentes anti-tumorais. O tratamento com GC confere, às células ST1, um crescimento totalmente dependente de soro e ancoragem, morfologia em cultura semelhante à de fibroblastos normais e incapacidade de gerar tumor em camundongos da linhagem \"nude\", caracterizando uma completa reversão fenotípica tanto in vitro como in vivo. Como abordagens para o entendimento do mecanismo molecular da ação de GCs, o laboratório vem buscando a clonagem de produtos gênicos diferencialmente expressos através do uso de técnicas que permitam a análise da abundância relativa dos mRNAs, e mais recentemente, empregando-se a análise da abundância relativa das proteínas através da eletroforese bidimensional (2D-PAGE). As seqüências isoladas por estas metodologias são alvos potenciais para uma posterior análise funcional. Os objetivos gerais deste trabalho foram: a) identificar genes que estão diferencialmente expressos durante a reversão fenotípica das células ST1 induzida por GC, através da análise proteômica (2D-PAGE e espectrometria de massas) e b) determinar a função de um dos genes (Ciclina G) identificado anteriormente no laboratório como sendo induzido durante o tratamento das células ST1 com GC. A metodologia empregada se baseou na comparação dos perfis 2D de proteínas nucleares das células ST1 tratadas ou não (controle) com GC por 5 e 24h. Após análise de imagem, 33 polipeptídios foram considerados como diferencialmente representados após 5h de tratamento, 16 dos quais foram também identificados após 24h de tratamento. Seis destes polipeptídios foram identificados através da análise dos seus perfis de digestão tríptica (PMF). Evidências obtidas por ensaios de Western blot sugerem que um destes polipeptídeos, a Anexina 2 (ANX2), possui a sua localização sub-celular modulada pela ação de GC nas células ST1. A análise do papel da Ciclina G na reversão fenotípica tumoral-normal das células ST1 induzida por GC, foi feita através da sua super-expressão nestas células, utilizando um sistema retroviral, e avaliando-se os efeitos desta super-expressão sobre a resposta das células ST1 a GC, através de ensaios de curva de crescimento e citometria de fluxo. Os dados sugerem que a super-expressão da Ciclina G nas células ST1 intensifica e prolonga o efeito de GC nestas células. / The glucocorticoid (GC) growth suppression response is controlled through cellular cascades in which the transcription of primary response genes regulates the expression and activity of a diverse set of genes including important factors for cell cycle progression. However, the functional connection between the GC-regulated transcriptional events and cell cycle arrest of determined cells is poorly understood at the molecular level. In this context, our lab has isolated the ST1 variant of the C6 rat glioma cell line to study the mechanism of action of GC as anti-tumor agents. GC treatment leads ST1 cells to a dramatic tumoral to normal phenotypic reversion, characterized by inhibition of their growth rate in monolayer, loss of their ability to form colonies in semi-solid medium and to induce tumor formation in nude mice, and morphological changes (flattening). As part of the strategy to understand the anti-tumor action of GC, differentially represented proteins, associated with the phenotypic reversion displayed by ST1 cells have been isolated through mRNA-based blind cDNA cloning and, more recently, by two dimensional electrophoresis (2D-PAGE). The sequences isolated by these two methodologies are potential targets for functional analysis. In the present study, we aimed at a) identifying genes which are differentially expressed during the GC-induced phenotypic reversion of ST1 cells, using the proteomic approach (2D-PAGE and mass spectrometry) and b) determining the functional role of a gene (Cyclin G) which had previously being identified as being induced during GC-treatment of the ST1 cells. The analytical methodology used relied on the comparison of sets of 2D nuclear protein profiles of ST1 cells, maintained in the absence (control) and in the presence of GC for 5 and 24h. After image analysis and visual validation, 33 polypeptides were considered as differentially represented 5 h after treatment, 16 of which were also differentially represented after 24 h. Six of those polypeptides were identified by peptide mass fingerprinting (PMF). Evidence obtained by Western blot analysis indicates that one of those polypeptides, Annexin 2 (ANX2), has its sub-cellular location modulated by GC-treatment of ST1 cells. The role of Cyclin G in the tumoral to normal phenotypic reversion induced by GC in ST1 cells was analyzed by over-expression of Cyclin G using a retroviral system and evaluation of the effects of this over-expression over ST1 cells response to GC, by growth curve and flow cytometry assays. The data suggest that Cyclin G over-expression leads to a more intense and prolonged effect of GC on ST1 cells.

Neoplasias malignas das glândulas salivares são lesões raras e o mecanismo pelo qual esses tumores progridem ainda não está completamente esclarecido na literatura. A galectina-3 é uma proteína multifuncional expressa em uma grande quantidade de tecidos normais, mas que também tem sido associada à progressão tumoral de neoplasias malignas da tireóide, próstata e neoplasias gástricas. Estudos prévios demonstraram que a galectina-3 está também expressa em algumas neoplasias malignas das glândulas salivares como carcinoma adenóide cístico e adenocarcinoma polimorfo de baixo grau de malignidade. Recentemente foi sugerido que a superexpressão da galectina-3 controla alterações nos níveis de expressão de alguns reguladores do ciclo celular, dentre eles a ciclina D1. Além disso, outros estudos revelaram que a ciclina D1 é ativada pela -catenina de uma maneira dependente da galectina-3. O objetivo desse trabalho foi comparar a marcação imunoistoquímica nuclear e / ou citoplasmática da galectina-3 no carcinoma adenóide cístico e adenocarcinoma polimorfo de baixo grau tentando relacioná-la à marcação da -catenina e ciclina D1. Foram realizadas reações de imunoistoquímica para as três proteínas em 15 casos de carcinoma adenóide cístico e em 15 casos de adenocarcinoma polimorfo de baixo grau utilizando-se material parafinado. Para a galectina-3 os carcinomas adenóides císticos apresentaram marcação imunoistoquímica apenas nas células luminais, predominantemente no núcleo. Todos os casos de adenocarcinoma polimorfo de baixo grau revelaram uma marcação predominantemente citoplasmática para essa proteína. Ambos os tumores exibiram intensa marcação citoplasmática e/ou nuclear para a -catenina na maioria dos casos. Não houve imunorreatividade para a ciclina D1 em 14/15 casos de adenocarcinoma polimorfo de baixo grau. Em contraste, os carcinomas adenóides císticos revelaram marcação nuclear específica para a ciclina D1 em 10 de 15 casos estudados em mais de 5% das células neoplásicas e essa marcação estava associada à marcação citoplasmática e nuclear da galectina-3 (p<0,05). Esses resultados sugerem que nos carcinomas adenóides císticos a expressão da galectina-3 pode exercer uma função de proliferação celular e parece estar relacionada à diferenciação celular no adenocarcinoma polimorfo de baixo grau. Além disso, a perda de expressão da galectina-3 no carcinoma adenóide cístico pode estar associada a um comportamento clínico mais agressivo dessa lesão. Embora a -catenina pareça exercer algum papel no mecanismo de carcinogênese dessas duas lesões, ela não parece se ligar à galectina-3 para ativar a ciclina D1. / Salivary gland tumors are uncommon and the mechanism by which malignant tumors progresses is still undefined. In a previous study it was shown that galectin-3 is expressed in malignant salivary gland neoplasms as adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma. Galectin-3 is a multifunctional protein of a group of galactoside-binding lectins expressed in a variety of normal cells, but also has been implicated in tumor progression of some malignancies as thyroid, prostate and gastric cancers. Recently, it has been suggested that galectin-3 may be an important mediator of the -catenin/Wnt pathway. Moreover, nuclear galectin-3 expression has been implicated in cell proliferation, promoting cyclin D1 activation. Thus, in the present study we aimed to correlate galectin-3 expression, either nuclear or cytoplasmic, with the expression of -catenin (nuclear/cytoplasmic) and cyclin D1 (nuclear) in 15 cases of adenoid cystic carcinoma and in 15 cases of polymorphous low-grade adenocarcinoma. For galectin-3, adenoid cystic carcinomas showed specific staining only in luminal cells, mainly in the nuclei. In the cases of polymorphous low-grade adenocarcinoma, all tumor cells revealed a positive, mostly cytoplasmic, reaction to galectin-3. Both tumors showed intense cytoplasmic/nuclear staining for -catenin in the majority of cases. Cyclin D1 immunoreactivity was not detected in 14 of the 15 polymorphous low-grade adenocarcinomas studied. In contrast, adenoid cystic carcinomas showed specific nuclear staining for cyclin D1 in 10 of 15 cases studied in more than 5% of the neoplastic cells. Cyclin D1 expression was correlated with cytoplasmic and nuclear galectin-3 expression in adenoid cystic carcinomas (p<0,05). These results suggest that in adenoid cystic carcinoma galectin-3 may play a role in cellular proliferation through cyclin D1 activation. In polymorphous low-grade adenocarcinoma gal-3 expression seems to be associated with cellular differentiation. In addition, loss of cytoplasmic expression of galectin-3 in adenoid cystic carcinomas may be related to a more aggressive behavior of these lesions. Although -catenin seems to play a role in carcinogenesis, in both lesions, it seems that it does not bind to galectin-3 for cyclin D1 stimulation.